Loading…
Loading grant details…
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | University of Maryland Baltimore County |
| Country | United States |
| Start Date | Sep 20, 2023 |
| End Date | Aug 31, 2025 |
| Duration | 711 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10725728 |
Project Summary: Ovarian cancer is the most lethal gynecologic malignancy and the fifth leading cause for cancer-related deaths among women in the United States. Due to the absence of reliable early biomarkers, more than 85% patients are diagnosed with metastatic disease that are resistant to extant chemotherapeutics. Consequently, the 5-year
survival rate for these patients is extremely poor (
University of Maryland Baltimore County
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant